World's Best Scientists 2026 revealed!
Rossella Elisei

Rossella Elisei

D-Index & Metrics

Medicine

D-Index
97
Citations
41582
World Ranking
9156
National Ranking
316

Rossella Elisei publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rossella Elisei sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 538 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rossella Elisei D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rossella Elisei sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rossella Elisei is affiliated with the University of Pisa in Italy and has made significant contributions primarily in the field of Medicine, with a focus on Endocrinology, Diabetes and Metabolism, Surgery, Oncology, Genetics, and Radiology, Nuclear Medicine and Imaging.

Their work extensively covers topics related to thyroid cancer diagnosis and treatment as well as thyroid and parathyroid surgery. Additional research topics include BRCA gene mutations in cancer, neuroendocrine tumor research advances, thyroid disorders and treatments, head and neck anomalies, and cancer-related molecular pathways.

Their frequent co-authors include:

  • Antonio Matrone
  • Eleonora Molinaro
  • Alessandro Prete
  • Carla Gambale
  • Cristina Romei

Rossella Elisei has published widely in several journals. The most common publication venues are:

  • Endocrine Abstracts
  • L Endocrinologo
  • Thyroid
  • The Journal of Clinical Endocrinology & Metabolism
  • Journal of Endocrinological Investigation

Selected recent publications include:

  • "Phase 3 Trial of Selpercatinib in Advanced RET -Mutant Medullary Thyroid Cancer," 2023, New England Journal of Medicine
  • "2022 European Thyroid Association Guidelines for the Management of Pediatric Thyroid Nodules and Differentiated Thyroid Carcinoma," 2022, European Thyroid Journal
  • "A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer," 2021, International Journal of Molecular Sciences
  • "A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer," 2021, Thyroid
  • "Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities," 2021, International Journal of Molecular Sciences

Best Publications

  • European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

    Furio Pacini;Martin Schlumberger;Henning Dralle;Rossella Elisei

  • Revised American thyroid association guidelines for the management of medullary thyroid carcinoma

    Samuel A Wells;Sylvia L Asa;Henning Dralle;Rossella Elisei

  • Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

    Martin Schlumberger;Makoto Tahara;Lori J. Wirth;Bruce Robinson

  • Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

    Samuel A. Wells;Bruce G. Robinson;Robert F. Gagel;Henning Dralle

  • Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

    Marcia S Brose;Christopher M Nutting;Barbara Jarzab;Rossella Elisei

  • Cabozantinib in Progressive Medullary Thyroid Cancer

    Rossella Elisei;Martin J. Schlumberger;Stefan P. Müller;Patrick Schöffski

  • Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

    Michael Mingzhao Xing;Ali S. Alzahrani;Kathryn A. Carson;David Viola

  • Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid Disorders

    Rossella Elisei;Valeria Bottici;Fabiana Luchetti;Giancarlo Di Coscio

  • BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.

    Rossella Elisei;Clara Ugolini;David Viola;Cristiana Lupi

  • Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

    F Pacini;F Pacini;Pw Ladenson;M Schlumberger;A Driedger

  • Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer

    Mingzhao Xing;Ali S. Alzahrani;Kathryn A. Carson;Young Kee Shong

  • Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

    Rossella Elisei;Barbara Cosci;Cristina Romei;Valeria Bottici

  • Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Combined with Neck Ultrasonography Has the Highest Sensitivity in Monitoring Differentiated Thyroid Carcinoma

    F Pacini;Eleonora Molinaro;Mg Castagna;Laura Agate

  • Association of BRAF V600E Mutation with Poor Clinicopathological Outcomes in 500 Consecutive Cases of Papillary Thyroid Carcinoma

    Cristiana Lupi;Riccardo Giannini;Clara Ugolini;Agnese Proietti

  • Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies

    Eleonora Molinaro;Cristina Romei;Agnese Biagini;Elena Sabini

  • Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma

    F Pacini;M Fontanelli;L Fugazzola;Rossella Elisei

  • Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer

    Martin J. Schlumberger;Rossella Elisei;Lars Bastholt;Lori J. Wirth

  • RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.

    Rossella Elisei;Cristina Romei;Tatiana Vorontsova;Barbara Cosci

  • Diagnostic 131-Iodine Whole-Body Scan May Be Avoided in Thyroid Cancer Patients Who Have Undetectable Stimulated Serum Tg Levels After Initial Treatment

    F Pacini;M Capezzone;Rossella Elisei;C Ceccarelli

  • Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.

    Furio Pacini;Francesco Lippi;Nunzio Formica;Rossella Elisei

Frequent Co-Authors

Aldo Pinchera
Aldo Pinchera University of Pisa
Fulvio Basolo
Fulvio Basolo University of Pisa
Furio Pacini
Furio Pacini University of Siena
Paolo Vitti
Paolo Vitti University of Pisa
Paolo Miccoli
Paolo Miccoli University of Pisa
Martin Schlumberger
Martin Schlumberger University of Paris-Saclay
Steven I. Sherman
Steven I. Sherman The University of Texas MD Anderson Cancer Center
Bruce G. Robinson
Bruce G. Robinson University of Sydney
Kari Hemminki
Kari Hemminki Charles University
Stefano Landi
Stefano Landi University of Pisa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up a wide range of online degree options, especially if you have a background in nursing or are considering a transition into healthcare. Many students interested in advancing their roles or shifting into nursing are looking for flexible, affordable educational pathways.

For those aiming for leadership or research positions in healthcare, phd in nursing online programs offer a path to the highest levels of academic and clinical practice. If you're already an RN seeking greater career opportunities, the cheapest rn to bsn programs help you earn your bachelor's degree without breaking the bank.

For non-nurses with a bachelor’s degree in another field who want to become nurses quickly, direct entry msn programs for non nurses online provide a fast-track into advanced nursing roles. Similarly, if you are searching for accessible entry points into nursing, online adn programs for non nurses are available, often with less stringent admission requirements.

Each of these pathways can help diversify your career in healthcare, making it easier to balance education, work, and personal commitments.

Best Scientists Citing Rossella Elisei

Trending Scientists

Recently Published Articles